Stock BCART BIOCARTIS GROUP NV
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Biocartis Group NV

Equities

BCART

BE0974281132

Real-time Euronext Bruxelles
Other stock markets
 11:35:06 2023-09-22 am EDT 		5-day change 1st Jan Change
0.29 EUR +1.05% Intraday chart for Biocartis Group NV -.--% -.--%
2023 Biocartis Group NV Presents Four Abstracts Showing Excellent Data for Idylla at European Society of Molecular Oncology Congress CI
2023 Biocartis, APIS Assay Technologies to Commercialize Estrogen Receptor-positive Mutations Kit MT

Evolution of the average Target Price on Biocartis Group NV

Price target over the last 5 years

History of analyst recommendation changes

3035.owy_Vnl7qtAnY5mYHJtT7mFG0Z4VGmom8tw9UIGi2EY.4WTzND1K_LZBFMH8V-s2gjUxmOx6aBN8qI1eBLeU7DDBdfAgKDLPm2wU6g~89f47d6f7c0e68ab432ec8a8504c4bc1

Analyst Recommendations on Biocartis Group NV

Berenberg Diagnostics Conference FA
Biocartis' Lung Cancer Test Shown to Improve Patient Survival Rates in UK Study MT
Exane BNP Paribas Diagnostics Imaging &Life Sciences CEO Conference FA
Berenberg European Opportunities Conference FA
Berenberg Belgian Conference FA
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.29 EUR
Average target price
1.1 EUR
Spread / Average Target
+279.31%
High Price Target
1.1 EUR
Spread / Highest target
+279.31%
Low Price Target
1.1 EUR
Spread / Lowest Target
+279.31%

Consensus detail

Consensus revision (last 18 months)

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BCART Stock
  4. Consensus Biocartis Group NV